SRPT: the stock had gapped up from positive clinical trial results.  It had also created new support at $45.  Additionally,  Benzinga gave an analyst upgrade from $64 to $81.

 

ALNY: Gapped down 12%.  During premarket, the stock had bounced off of the lows of $67.  But it should hold strong support at $70

 

JUNO: It is creating an ascending triangle.  Break over $44

 

NLNK: Strong uptrend, looking for a dip buy

 

GPRO:  Earnings winner. Support is at $10

 

CONN: Strong uptrend,  If it can break the day high of $22, the next resistance level would be $22.96

 

TRVG: could panic more, if so there could be a dip buy opportunity